Hanauer et al listed criteria for response to therapy in patients with ulcerative colitis (UC). The authors are from the University of Chicago, the Mayo Clinic, Mount Sinai School of Medicine, Long Island Clinical Research Associates, Greater Cincinnati Gastroenterology Associates, Richmond Gastroenterology Associates and Proctor & Gamble Pharmaceuticals.
